 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

In trading on Wednesday, the ARK Genomic Revolution ETF is outperforming other ETFs, up about 1.7% on the day. Components of that ETF showing particular strength include shares of 908 Devices, up...

Video: Wednesday's ETF Movers: ARKG, LIT

908 Devices Inc. (NASDAQ:MASS  Get Free Report) was the target of a significant decrease in short interest in October. As of October 31st, there was short interest totalling 1,360,000 shares...

Short Interest in 908 Devices Inc. (NASDAQ:MASS) Decreases By 6.2%

This indicator may be signaling that MASS's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

908 Devices (MASS, $6.14) entered Downtrend as Momentum indicator drops below 0 level on Nov 16, 2023

908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today announced that it has expanded access to its leading trace...

908 Devices Announces MX908 Integration Capabilities

908 Devices (MASS, $4.95) entered Downtrend as Momentum indicator drops below 0 level on Nov 09, 2023

908 Devices (NASDAQ:MASS  Get Free Report) posted its earnings results on Tuesday. The company reported ($0.22) earnings per share for the quarter, topping the consensus estimate of ($0.30) by...

908 Devices (NASDAQ:MASS) Issues Quarterly  Earnings Results

908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today reported financial results for the quarter ended September 30...

908 Devices Reports Third Quarter 2023 Financial Results and Narrows 2023 Revenue Outlook

908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, and medical technology company Terumo Blood and Cell Technologies...

908 Devices and Terumo Blood and Cell Technologies Collaborate to Add On-line Analytics to Quantum Flex Cell Expansion System

For the last three days, A.I.dvisor has detected that MASS's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...

908 Devices (MASS, $6.3) Aroon Indicator entered a Downtrend on November 02, 2023.

908 Devices (MASS, $6.17) Aroon Indicator entered a Downtrend on November 01, 2023.

908 Devices, Inc. engages in the development of measurement devices for chemical and biochemical analysis. It offers products using mass spectrometry technology, an analytical technique for measuring the mass of charged molecules that is used in chemical analysis laboratories for applications, such as safety and security, food science, biotechnology, clinical diagnostics, and controlling industrial processes. Its products include desktops and handhelds. The company was founded by Kevin J. Knopp, Miller Scott, Steve Araiza, Andrew Bartfay, Michael Jobin, Christopher D. Brown, and Christopher J. Petty in 2012 and is headquartered in Boston, MA.

Watchers	767
52-Wk Low	$4.85
52-Wk High	$11.26

Market Cap	$221.8M
Volume (M)	230,235.00
52-Wk High	$11.26
52-Wk Low	$4.85

Current Price	$7.76
Prev Close	$7.19
Open	$7.26
Dividend Yield	0.00%
50-Day Moving Average	$6.05
Beta	2.01
Avg. Volume	134,966.32
PE Ratio	-5.94

52-Week High	$11.26
52-Week Low	$4.85
Market Capitalization	$221.8M
EPS	-$1.21
Price to Book	1.37
Revenue Per Employee	$698,838.23
Enterprise Value/EBITDA	-1.83

MASS 908 Devices Inc

About

Feed

News

Sentiment

Earnings

Fundamentals